Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I trial of MVA-H5 influenza vaccine in healthy adults
NL-OMON38408Phase 1Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1 trial of MVA-H5-sfMR vaccine in influenza, sponsored by Erasmus MC. Primary endpoint: Safety of the vaccine. Started Dec 2012; status: active, not recruiting.
02
Drugs
MVA-H5-sfMR vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON38408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38408.